This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

WuXi PharmaTech (Cayman) Inc (WX)

NYSE: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 112.16M 114.57M 86.58M 80.98M
Operating Gains/Losses 5.16M -4.04M 1.28M 1.36M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -37.47M -28.37M -27.31M -14.40M
(Increase) Decrease in Inventories -4.55M 3.64M -3.18M -26.81M
(Increase) Decrease In Other Current Assets -21.06M -3.72M 1.25M -332.00K
(Decrease) Increase In Payables 1.98M 9.50M 1.63M 5.02M
(Decrease) Increase In Other Current Liabilities 15.56M 10.26M 13.82M -2.03M
(Increase) Decrease In Other Working Capital -2.41M 16.48M 1.34M 8.80M
Other Non-Cash Items 24.65M 18.45M 13.96M 14.47M
Net Cash From Continuing Operations 140.38M 181.51M 131.06M 101.06M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 140.38M 181.51M 131.06M 101.06M
Sale of Property, Plant & Equipment 4.52M 18.33M 69.00K 77.00K
Cash Used for Investing Activities
Sale of Short-Term Investments 471.56M 372.56M 259.28M 196.16M
Purchases of Property, Plant & Equipment -108.12M -60.14M -67.84M -76.72M
Acquisitions -23.87M -489.00K 0.00 -12.56M
Purchases of Short-Term Investments -372.86M -491.88M -305.58M -280.77M
Other Cash from Investing Activities 8.65M 1.53M 6.81M -396.00K
Cash Provided by Financing Activities
Net Cash From Investing Activities -53.16M -165.42M -117.58M -178.53M
Issuance of Debt 219.42M 76.68M 81.50M 55.95M
Cash Used for Financing Activities
Issuance of Capital Stock 2.22M 4.95M 1.38M 1.64M
Repayment of Long-Term Debt -84.63M -62.54M -47.12M -27.82M
Repurchase of Capital Stock -98.88M -1.16M -67.00M 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 0.00 0.00 0.00 0.00
Net Cash From Financing Activities 38.14M 17.93M -31.24M 29.77M
Effect of Exchange Rate Changes -2.78M 717.00K 526.00K 3.66M
Net Change in Cash & Cash Equivalents 122.58M 34.74M -17.24M -44.03M
WX News

WX WuXi PharmaTech (Cayman) Inc

Chart of WX

Analysts Ratings for WX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 4 4
Moderate Buy 0 0 0 0
Hold 4 4 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

WX Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs